Rani Therapeutics Holdings Inc Cl A (RANI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 18,618 | 3,762 | 5,864 | 27,007 | 117,453 |
| Marketable Securities | 31,091 | 23,877 | 42,675 | 71,475 | N/A |
| Receivables | 2,042 | N/A | N/A | N/A | N/A |
| Other current assets | 0 | 428 | 0 | 0 | 0 |
| TOTAL | $53,321 | $29,744 | $50,847 | $100,924 | $119,595 |
| Non-Current Assets | |||||
| PPE Net | 736 | 1,548 | 6,105 | 6,038 | 4,612 |
| Other Non-Current Assets | 4,564 | 5,342 | 964 | 1,065 | 0 |
| TOTAL | $5,300 | $6,890 | $7,069 | $7,103 | $4,612 |
| Total Assets | $58,621 | $36,634 | $57,916 | $108,027 | $124,207 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 15,000 | 4,897 | N/A | N/A |
| Accounts payable and accrued liabilities | 309 | 1,359 | 648 | 1,460 | 1,206 |
| Accrued Expenses | 3,943 | 2,073 | 1,726 | 2,349 | 1,434 |
| TOTAL | $12,669 | $19,891 | $7,989 | $4,815 | $2,640 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 9,613 | 24,484 | 29,149 | N/A |
| Deferred Revenues | 6,831 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 14,009 | 30,203 | 33,913 | 32,815 | 44,757 |
| TOTAL | $4,440 | $13,250 | $24,484 | $29,208 | $N/A |
| Total Liabilities | $17,109 | $33,141 | $32,473 | $34,023 | $2,640 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 123,692 | 57,482 | 50,157 | 49,412 | 49,160 |
| Common Shares | 11 | 5 | 5 | 5 | 5 |
| Retained earnings | -132,580 | -102,907 | -72,889 | -38,919 | -8,331 |
| Other shareholders' equity | 8,503 | 1,506 | 12,565 | 37,076 | 74,156 |
| TOTAL | $41,512 | $3,493 | $25,443 | $74,004 | $121,567 |
| Total Liabilities And Equity | $58,621 | $36,634 | $57,916 | $108,027 | $124,207 |